Yu Ming Hu
#165,462
Most Influential Person Now
Yu Ming Hu's AcademicInfluence.com Rankings
Yu Ming Humedical Degrees
Medical
#3400
World Rank
#3868
Historical Rank
Neurology
#312
World Rank
#395
Historical Rank
Yu Ming Huphilosophy Degrees
Philosophy
#9722
World Rank
#13323
Historical Rank
Logic
#6687
World Rank
#8231
Historical Rank
Download Badge
Medical Philosophy
Yu Ming Hu's Degrees
- Doctorate Medicine Wuhan University
Why Is Yu Ming Hu Influential?
(Suggest an Edit or Addition)Yu Ming Hu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. (2020) (5288)
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) (1949)
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. (2020) (1097)
- Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study (2020) (337)
- Venetoclax plus LDAC for patients with untreated AML ineligible for intensive chemotherapy: phase 3 randomized placebo-controlled trial. (2020) (271)
- Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31) (2016) (252)
- Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome (2020) (218)
- Multi-organ proteomic landscape of COVID-19 autopsies (2020) (198)
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research (2020) (194)
- LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. (2013) (176)
- Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study (2020) (168)
- Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome. (2020) (143)
- Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study (2020) (126)
- Controlling Cytokine Storm Is Vital in COVID-19 (2020) (103)
- Hematological features of persons with COVID-19 (2020) (103)
- Risk factors for death in 1859 subjects with COVID-19 (2020) (102)
- Fibrin-targeting peptide CREKA-conjugated multi-walled carbon nanotubes for self-amplified photothermal therapy of tumor. (2016) (95)
- Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery (2017) (92)
- Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China (2020) (91)
- Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina. (2015) (84)
- The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis. (2017) (83)
- Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma. (2020) (83)
- Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic (2020) (82)
- LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway (2019) (77)
- Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158] (2020) (71)
- Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis (2018) (71)
- Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation (2019) (70)
- Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma. (2015) (67)
- MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway (2017) (65)
- BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress (2020) (64)
- The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis (2020) (63)
- A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial (2019) (61)
- Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China (2020) (60)
- Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis (2018) (59)
- Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial (2019) (56)
- UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma. (2015) (55)
- Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy (2019) (54)
- Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury (2020) (53)
- Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer. (2016) (52)
- MicroRNA‐324‐5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling (2018) (51)
- Chinese guidelines for treatment of adult primary immune thrombocytopenia (2018) (51)
- Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. (2020) (50)
- Ethnic diversity in the genetics of venous thromboembolism (2015) (50)
- Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study. (2020) (49)
- A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma (2021) (48)
- Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy (2020) (47)
- Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas. (2017) (47)
- Poor clinical outcomes for patients with cancer during the COVID-19 pandemic (2020) (46)
- Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. (2016) (46)
- Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan (2020) (45)
- Thrombocytopenia and thrombosis in hospitalized patients with COVID-19 (2020) (45)
- Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease (2019) (44)
- EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery. (2010) (43)
- Venous Thromboembolism in COVID-19 (2020) (43)
- Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy (2016) (43)
- Anti-CD19 CAR-T Therapy Bridging to Allo-HSCT for Relapsed/refractory B-cell Acute Lymphoblastic Leukemia: An Open-Label Pragmatic Clinical Trial. (2019) (42)
- Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow–derived mesenchymal stem cells and slow age-related degeneration (2021) (42)
- Obesity is a potential risk factor contributing to clinical manifestations of COVID-19 (2020) (42)
- Genetic Background Analysis of Protein C Deficiency Demonstrates a Recurrent Mutation Associated with Venous Thrombosis in Chinese Population (2012) (42)
- Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice (2017) (41)
- Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia (2020) (40)
- Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID‐19 patients: A multicenter retrospective study (2021) (39)
- miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma. (2019) (37)
- Hemophagocytic lymphohistiocytosis after COVID-19 vaccination (2021) (36)
- Neurological toxicities and coagulation disorders in the cytokine release syndrome during CAR‐T therapy (2018) (36)
- Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction (2018) (35)
- Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission (2020) (34)
- Optimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy (2016) (34)
- MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer (2019) (34)
- NEMO Modulates Radiation-Induced Endothelial Senescence of Human Umbilical Veins Through NF-κB Signal Pathway (2015) (33)
- EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA Interference (2013) (33)
- Chronic Inflammation: A Common Promoter in Tertiary Lymphoid Organ Neogenesis (2019) (33)
- Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis (2018) (33)
- Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study. (2019) (32)
- Pathologic T-cell response in ischaemic failing hearts elucidated by T-cell receptor sequencing and phenotypic characterization. (2019) (30)
- A tissue factor targeted nanomedical system for thrombi-specific drug delivery. (2012) (30)
- Molecular basis of protein S deficiency in China (2013) (29)
- Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study (2018) (29)
- IL (Interleukin)-33 Suppresses Abdominal Aortic Aneurysm by Enhancing Regulatory T-Cell Expansion and Activity (2019) (28)
- Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis (2018) (28)
- Long-term infection of SARS-CoV-2 changed the body's immune status (2020) (28)
- Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels. (2017) (28)
- Complement in Hemolysis- and Thrombosis- Related Diseases (2020) (26)
- FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation (2021) (26)
- Correction to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway (2017) (26)
- Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis (2015) (25)
- Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017 (2018) (25)
- Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database (2019) (25)
- T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies (2021) (24)
- Air pollution and venous thrombosis: a meta-analysis (2016) (23)
- Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice. (2016) (23)
- Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma (2018) (23)
- Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4) (2021) (23)
- Genetic analysis should be included in clinical practice when screening for antithrombin deficiency (2014) (23)
- Corilagin Attenuates Radiation-Induced Brain Injury in Mice (2016) (22)
- Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells (2016) (21)
- Biomarkers in individualized management of chimeric antigen receptor T cell therapy (2020) (21)
- SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism (2021) (21)
- Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China. (2012) (20)
- Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China (2021) (20)
- Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis (2021) (19)
- A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia (2021) (19)
- A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation. (2019) (19)
- PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4. (2014) (19)
- Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation (2015) (19)
- Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia (2018) (19)
- Prophylactic effects of interleukin-2 receptor antagonists against graft-versus-host disease following unrelated donor peripheral blood stem cell transplantation. (2012) (19)
- Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features (2020) (18)
- Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS. (2008) (18)
- Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study (2019) (18)
- Long-Term Effects of COVID-19 on Health Care Workers 1-Year Post-Discharge in Wuhan (2021) (18)
- Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study (2017) (18)
- Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study (2018) (17)
- CD2‐Associated Protein Contributes to Hepatitis C, Virus Propagation and Steatosis by Disrupting Insulin Signaling (2018) (17)
- Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why? (2020) (17)
- Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis (2021) (17)
- Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. (2019) (16)
- A 4‐microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia (2018) (16)
- SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation. (2020) (16)
- Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer (2018) (16)
- Novel BCR-ABL1 Tyrosine Kinase Inhibitor (TKI) HQP1351 (Olverembatinib) Is Efficacious and Well Tolerated in Patients with T315I-Mutated Chronic Myeloid Leukemia (CML): Results of Pivotal (Phase II) Trials (2020) (15)
- How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application (2020) (15)
- Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study (2020) (15)
- Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial) (2021) (15)
- Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A (2017) (14)
- Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program (2017) (14)
- Early coagulation tests predict risk stratification and prognosis of COVID-19 (2020) (14)
- COVID-19 Diagnosis (2020) (14)
- Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy. (2016) (14)
- Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms (2021) (14)
- DIC in COVID-19 (2021) (14)
- Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study (2020) (14)
- Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era (2019) (13)
- Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer’s Disease (2021) (13)
- Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia (2019) (13)
- Comparison of outcomes of idarubicin intensified TBI-CY and traditional TBI-CY conditioning regimen for high-risk acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A single center experience. (2015) (13)
- Treatments in the COVID-19 pandemic: an update on clinical trials (2020) (13)
- Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study (2021) (13)
- Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis (2018) (12)
- Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1 (2020) (12)
- Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion (2018) (12)
- Clinical significance of chromosomal abnormalities detected by interphase fluorescence in situ hybridization in newly diagnosed multiple myeloma patients. (2011) (12)
- Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study (2016) (12)
- Efficacy and safety of intravenous thrombolysis for acute ischemic stroke in cancer patients: a systemic review and meta-analysis. (2020) (12)
- Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies (2020) (11)
- Compound heterozygous protein C deficiency in a family with venous thrombosis: Identification and in vitro study of p.Asp297His and p.Val420Leu mutations. (2015) (11)
- A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy (2016) (11)
- Interleukin 35 ameliorates myocardial ischemia‐reperfusion injury by activating the gp130‐STAT3 axis (2020) (11)
- Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients (2020) (11)
- Efficacy and Safety of Panobinostat in Relapsed or/and Refractory Multiple Myeloma: Meta Analyses of Clinical Trials and Systematic Review (2016) (11)
- Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells (2018) (10)
- Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis (2021) (10)
- The delivery of thrombi-specific nanoparticles incorporating oligonucleotides into injured cerebrovascular endothelium. (2013) (10)
- Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis (2022) (10)
- Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis (2020) (10)
- Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk (2016) (10)
- Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models (2021) (10)
- First‐in‐patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura (2020) (10)
- PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report (2021) (10)
- Inhibition of PGC-1α after chemotherapy-mediated insult confines multiple myeloma cell survival by affecting ROS accumulation. (2015) (10)
- Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients: a Meta-analysis (2018) (10)
- Development of pancytopenia in a patient with COVID‐19 (2020) (10)
- Sintilimab for relapsed/refractory (r/r) extranodal NK/T cell lymphoma (ENKTL): Extended follow-up on the multicenter, single-arm phase II trail (ORIENT-4). (2020) (10)
- Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study. (2016) (9)
- JunB is a key regulator of multiple myeloma bone marrow angiogenesis (2021) (9)
- [Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.]. (2009) (9)
- Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation (2020) (9)
- Binding of EGF1 domain peptide in coagulation factor VII with tissue factor and its implications for the triggering of coagulation (2010) (9)
- Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance (2018) (9)
- Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis. (2019) (9)
- Reduced cardiac function and risk of venous thromboembolism in Asian countries (2017) (9)
- Pooled Analysis of Safety Data from Clinical Trials of Orelabrutinib Monotherapy in Hematologic Malignancies (2020) (8)
- Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae (2021) (8)
- Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL) (2015) (8)
- Surgery shows survival benefit in patients with primary intestinal diffuse large B‐cell lymphoma: A population‐based study (2021) (8)
- PECAM-1 Protects against DIC by Dampening Inflammatory Responses via Inhibiting Macrophage Pyroptosis and Restoring Vascular Barrier Integrity. (2020) (8)
- The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19 (2020) (8)
- Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population (2020) (8)
- Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study (2020) (8)
- Characteristics of mortal COVID-19 cases compared to the survivors (2020) (8)
- Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome. (2021) (8)
- PIDD Mediates Radiation-Induced Microglia Activation (2016) (8)
- Genetic analysis in Factor XI deficient patients from central China: identification of one novel and seven recurrent mutations. (2015) (7)
- A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia (2017) (7)
- Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis (2019) (7)
- Targeting hemostasis-related moieties for tumor treatment. (2020) (7)
- Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies (2018) (7)
- CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation (2021) (7)
- Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency (2020) (7)
- Immune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer (2012) (7)
- MM-BMSCs induce naïve CD4+ T lymphocytes dysfunction through fibroblast activation protein α. (2017) (7)
- Reduced-intensity versus Myeloablative Conditioning Regimens for Younger Adults with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A systematic review and meta-analysis (2020) (6)
- Updated Results from the Phase II Study of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia (2020) (6)
- Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study (2018) (6)
- [Expression of fusion protein encoding EGFP-EGF1 of rat coagulation factor VII and its binding function]. (2008) (6)
- Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival (2021) (6)
- MicroRNA-324-5p suppresses the migration and invasion of MM cells by inhibiting the SCFβ-TrCP E3 ligase. (2018) (6)
- Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China (2016) (6)
- Updated Results of Pivotal Phase 2 Trials of Olverembatinib (HQP1351) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL1 T315I-Mutated Chronic- and Accelerated-Phase Chronic Myeloid Leukemia (CML-CP and CML-AP) (2021) (6)
- Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis (2019) (6)
- Factors Predicting Progression to Severe COVID-19: A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan, China (2021) (6)
- A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case (2017) (6)
- A multicentre double‐blind, double‐dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients (2021) (6)
- Sintilimab for relapsed/refractory (r/r) extranodal NK/T-cell lymphoma (ENKTL): A multicenter, single-arm, phase 2 trial (ORIENT-4). (2019) (5)
- Role of plasma high mobility group box-1 in disseminated intravascular coagulation with leukemia. (2015) (5)
- Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single‐arm, open‐label phase 2 study (2018) (5)
- Tissue Factor-Targeted “O2-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma (2020) (5)
- Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes (2020) (5)
- Sintilimab for Relapsed/Refractory Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial (ORIENT-4) (2020) (5)
- Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience (2016) (5)
- Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study (2021) (5)
- A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes (2020) (5)
- TGF-betal transgenic mouse model of thoracic irradiation: modulation of MMP-2 and MMP-9 in the lung tissue. (2006) (5)
- Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma. (2021) (5)
- Early diagnosis of cerebral thrombosis by EGFP–EGF1 protein conjugated ferroferric oxide magnetic nanoparticles (2019) (5)
- Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updated Long Term Results of Phase II Study (2021) (5)
- APOC3 may not be a predictor of risk of ischemic vascular disease in the Chinese population (2014) (4)
- BQ123 selectively improved tumor perfusion and enhanced nanomedicine delivery for glioblastomas treatment (2017) (4)
- Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis (2021) (4)
- Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia (2020) (4)
- The emerging role of non-coding RNAs from extracellular vesicles in Alzheimer's disease. (2021) (4)
- Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme (2021) (4)
- Thrombophilia Caused by Beta2-Glycoprotein I Deficiency: In Vitro Study of a Rare Mutation in APOH Gene (2018) (4)
- Nomogram for Predicting Deep Venous Thrombosis in Lower Extremity Fractures (2021) (4)
- Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study (2021) (4)
- Clinical features and prognostic factors of small cell lung cancer: A retrospective study in 148 patients (2016) (4)
- Transmission of 2019-nCoV to Health-Care Workers in the Early Epidemic (2020) (4)
- Mixed reality assists the fight against COVID-19 (2021) (4)
- CRISPR‐mediated deletion of the PECAM‐1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity (2018) (4)
- Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients (2019) (4)
- Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment (2021) (4)
- Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency (2017) (4)
- Identification of distinctive long noncoding RNA competitive interactions and a six‐methylated‐gene prognostic signature in acute myeloid leukemia with −5/del(5q) or −7/del(7q) (2020) (4)
- Roles of noncoding RNAs in drug resistance in multiple myeloma (2020) (4)
- Effect of EGF1 peptides in directing nanoparticles to thrombi (2010) (3)
- Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study (2022) (3)
- International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma (2021) (3)
- The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database (2021) (3)
- Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis (2021) (3)
- The Role of Noncoding RNAs in B-Cell Lymphoma (2020) (3)
- Fto Promotes Extramedullary Progression of Multiple Myeloma By Regulation of HSF1 through m6a RNA Methylation (2019) (3)
- Frontline flumatinib versus imatinib in patients with chronic myeloid leukemia in chronic phase: Results from the China randomized phase III study. (2019) (3)
- Liver Injury in patients with COVID-19: Clinical Profiles, CT findings and their Correlation with the Severity (2020) (3)
- Model-based cellular kinetic analysis of SARS-CoV-2 infection: different immune response modes and treatment strategies (2021) (3)
- Clinical characteristics of 1327 patients with coronavirus disease 2019 (COVID-19) in the largest Fangcang shelter hospital in Wuhan. (2020) (3)
- Phenotypic and genotypic characterization of four factor VII deficiency patients from central China (2015) (3)
- Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis (2020) (3)
- Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A (2021) (2)
- Lack of association between Factor V Hong Kong and Venous thrombosis in the Chinese population. (2015) (2)
- Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China (2018) (2)
- Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience (2020) (2)
- Nanopore-targeted sequencing for simultaneous diagnosis of suspected sepsis and early targeted therapy (2021) (2)
- Clinical Characteristics and Outcomes of Critically Ill Patients with Novel Coronavirus Infectious Disease (COVID-19) In China: A Retrospective Multicenter Descriptive Study (2020) (2)
- 791 A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with relapsed or refractory classic hodgkin lymphoma (cHL) (2020) (2)
- Updated Results of Pivotal Phase 2 Trials of Olverembatinib (HQP1351) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic- and Accelerated-Phase Chronic Myeloid Leukemia (CML-CP and CML-AP) with T315I Mutation (2022) (2)
- RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A (2021) (2)
- A Multicompartment Mathematical Model Based on Host Immunity for Dissecting COVID-19 Heterogeneity (2021) (2)
- Cardiovascular-specific mortality among multiple myeloma patients: a population-based study (2022) (2)
- Reply to “Mortality-related immune features and COVID-19” (2021) (2)
- Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China. (2017) (2)
- MM-BMSCs induce naïve CD4+ T lymphocytes dysfunction through fibroblast activation protein α (2017) (1)
- A Predominant Mutation in Regulatory Region of SERPINC1 Gene and Venous Thrombosis (2015) (1)
- 2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy (2022) (1)
- Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies (2019) (1)
- Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201) (2022) (1)
- Clinical Characteristics, Diagnosis, and Clinical Management of COVID-19 in Fifteen Patients with Haematological Disease – A Retrospective Analysis (2020) (1)
- 生态补偿机制效果研究述评——兼论微观效果研究框架的构建 ; Review of the Study on Consequences of Payment for Ecological Services: Constructing a Research Framework for Micro-effect Evaluation (2017) (1)
- Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections (2023) (1)
- Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy (2018) (1)
- Secondary Hemophagocytic Lymphohistiocytosis With Epstein–Barr Virus-Associated Transformed Follicular Lymphoma: A Case Report and Literature Review (2021) (1)
- A genetic analysis of 23 Chinese patients with hemophilia B (2016) (1)
- Immune‐related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia (2022) (1)
- Once Weekly Bortezomib Plus Dexamethasone in Newly Diagnosed Multiple Myeloma: A Preliminary Study in Chinese Patients (2011) (1)
- Brief report on the relation between complement C3a and anti dsDNA antibody in systemic lupus erythematosus (2022) (1)
- Progress in the research on venous thromboembolism (2017) (1)
- Disturbed MAPK pathway in early bilateral testicular extramedullary relapse of multiple myeloma. (2020) (1)
- CCL18 promotes migration and invasion of multiple myeloma cells and is associated with poor prognosis. (2022) (1)
- Thrombomodulin Gene Mutations Associated with Thromboembolic Diseases (2015) (1)
- Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients (2021) (1)
- Abnormal Coagulation Function in CD19-Targeted CAR-T Therapy (2017) (1)
- Corrigendum to "Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice" [Biomaterials (2016) 63-71]. (2021) (1)
- Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China (2017) (1)
- ICG/LY@HES-PCL Nanomedicine Improving the Efficacy of CAR-T Therapy in Lymphoma (2021) (1)
- Baseline Characteristics and Early Monitoring of Chinese CML Patients Treated with Dasatinib: Report from a Multicenter, Observational, Registry-Based Study (2016) (1)
- Atomic Level Dissection of the Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) Homophilic Binding Interface: Implications for Endothelial Cell Barrier Function (2021) (1)
- Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice (2022) (1)
- Retraction Note to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway (2020) (0)
- Asymmetric Bone Marrow Involvement in Patients with Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation：Two Case Reports and Literature Review (2020) (0)
- Efficacy and safety of novel oral anticoagulants for the treatment of cancer-associated venous thromboembolism: protocol for an umbrella review of systematic reviews and meta-analyses (2023) (0)
- A tissue factor-cascade-targeted nanoparticle forsite-directed inducing thrombosis (2017) (0)
- Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis (2018) (0)
- Comparison of the Three Scoring Systems— Ipss、Wpss、and IPSS-R in Predicting the Prognosis of MDS in Chinese (2017) (0)
- Role of cerebrospinal fluid chimerism in predicating central nervous relapse surveillance for patients of acute leukemia after allogeneic hematopoietic stem cell transplantation (2019) (0)
- A Novel Nonsense Mutation of F13A1 Gene Causing Inherited Factor XIII Deficiency in a Chinese Han Family (2011) (0)
- Supplementary research on K150del variant of activated protein C (2021) (0)
- Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study (2021) (0)
- Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial (2022) (0)
- Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology and End Results Database (2019) (0)
- Simvastatin Improves Outcomes of Endotoxin-induced Coagulopathy by Regulating Intestinal Microenvironment (2022) (0)
- Results from a Phase 2 Study of a Novel Janus Kinase Inhibitor in Treatment of Patients with Myelofibrosis (2021) (0)
- Novel Association of a F11 Variant with Venous Thromboembolism in a Chinese Han Population (2015) (0)
- The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study (2017) (0)
- Predominant mutations in a hotspot of SERPINC1 associated with venous thromboembolism in the Chinese population: a case-control study (2016) (0)
- Correction: Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency (2018) (0)
- Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis Following Unrelated Donor Peripheral Blood Stem Cell Transplantation, (2011) (0)
- An IPI based immune prognostic model for diffuse large B-cell lymphoma (2021) (0)
- Timing of Tocilizumab and Corticosteroids Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia (2021) (0)
- Diagnostic Performance and Prognostic Value of a Chinese Diagnostic Scoring System (CDSS) for Disseminated Intravascular Coagulation---a Multicenter Prospective Study (2017) (0)
- 20(S)-Protopanaxatriol Promotes Fatty Acid-Induced ER Stress and Apoptosis in Multiple Myeloma By Down-Regulating SCD1 Expression (2018) (0)
- Corilagin Attenuates Radiation-Induced Brain Injury in Mice (2015) (0)
- An overview of the role of D-dimer in COVID-19: elevated D-dimer level is associated with disease severity (2020) (0)
- Giardia lamblia mimicking acute graft versus host disease after allogeneic hematopoietic stem cell transplantation (2020) (0)
- A non-interventional, observational registry of adult patients with multiple myeloma treated with Revlimid (lenalidomide) in China: interim analysis (2015) (0)
- Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival (2021) (0)
- Association of thrombomodulin c.1418C>T polymorphism and venous thromboembolism. (2017) (0)
- Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis (2018) (0)
- Long-Term Infection of SARS-CoV-2 Evoked a Potential CD4+ T Cell Differentiation in Non-Critical Pneumonia Patients: A Prospective Study (2020) (0)
- What Can De Novo Protein Design Bring to the Treatment of Hematological Disorders? (2023) (0)
- Machine Learning and Integrative Analysis Reveals Stemness Index-associated Signature in Acute Myeloid Leukemia (2020) (0)
- Haplo-HSCT Is Superior to Chemotherapy for Standard Risk ALL in CR1—Results of Prospective Multicenter Trial (NCT02042690) (2019) (0)
- Lack of association of common polymorphism of LRP1 gene with myocardial infarction in a Chinese Han population (2011) (0)
- Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study (2017) (0)
- The Association Between SERPINC1 C.883G>a and VT in the Chinese Population (2015) (0)
- Convalescent Plasma Treatment in Severe and Life-Threatening COVID-19: A Randomized Controlled Clinical Trial (2020) (0)
- Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study (2017) (0)
- Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [Leuk Res. 2016 Jul;46:61-68.]. (2019) (0)
- [Clinical features of rituximab plus chemotherapy as first-line treatment in patients with diffuse large B-cell lymphoma]. (2014) (0)
- [Application Advance of Flow Cytometry in the CAR-T Cell Therapy--Review]. (2020) (0)
- Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree (2021) (0)
- Correction for: Supplementary research on K150del variant of activated protein C (2021) (0)
- A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma (2014) (0)
- COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China (2020) (0)
- Evaluation the Value of TAT, PIC, tPAIC, TM in Diagnosing Disseminated Intravascular Coagulation in Chinese population: a Multi-Center Prospective Observational Study (2017) (0)
- may not be a predictor of risk of ischemic vascular APOC 3 disease in the Chinese population (2016) (0)
- Signatures of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Patients with Acute Myeloid Leukemia (2019) (0)
- Simvastatin improves the prognosis of endotoxin-induced disseminated intravascular coagulation by regulating the intestinal microenvironment (2020) (0)
- Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis (2021) (0)
- Single-Cell Analyses Identify Transcriptional Characterizations of Subsets Associated with Efficacy and Toxicity for CAR-T Immunotherapy in B-ALL Patients (2021) (0)
- Bile Acid Reduces Thrombosis Risk By Inhibiting Noncatalytic Region of Tyrosine Kinase in Platelets (2022) (0)
- ABCL-256: Role of Radiotherapy Differs Between Stages for Primary Bone Large B-Cell Lymphoma in the Rituximab Era: A Real-World Study (2020) (0)
- Combined deficiency of factors V and VIII in a Chinese family due to a novel nonsense mutation in lectin mannose binding protein 1 (2020) (0)
- Serum Complement Protein C3a Level is Associated With Anti dsDNA Ab in Systemic Lupus Erythematosus: a Brief Report (2021) (0)
- APOC3 may not be a predictor of risk of ischemic vascular disease in the Chinese population. (2014) (0)
- Hematological Questions in Personalized Management of COVID-19 Vaccination (2023) (0)
- Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma (2021) (0)
- Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma (2017) (0)
- Incidence and Impact of Disseminated Intravascular Coagulation in COVID-19 (2020) (0)
- MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12 (2018) (0)
- Dual-targeting paclitaxel-loaded nanoparticles for the treatment of glioma in mice (2013) (0)
- Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017 (2018) (0)
- Present status and future orientation of rivaroxaban application in patients with nonvulvular atrial fibrillation. (2017) (0)
- [A multicenter study of rituximab-based regimen as first-line treatment in patients with follicular lymphoma]. (2014) (0)
- may not be a predictor of risk of ischemic APOC 3 vascular disease in the Chinese population (2016) (0)
- Heterozygous germline FLCN mutation in Birt–Hogg–Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report (2022) (0)
- Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis (2018) (0)
- Infectious Complications Following Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancy (2021) (0)
This paper list is powered by the following services:
